Is Regular Probiotic Practice Safe for Management of Sepsis?

Kumar, Rishabh; Tripathi, Alok Shiomurti; Sharma, Nidhi; Singh, Gaaminepreet; Mohapatra, Lucy

Kumar, Rishabh; Tripathi, Alok Shiomurti; Sharma, Nidhi; Singh, Gaaminepreet; Mohapatra, Lucy.

Afiliación

Kumar R; Department of Pharmacology, ISF College of Pharmacy, Moga (Punjab), India.
Tripathi AS; Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Lucknow (UP), India. astripathi@lko.amity.edu.
Sharma N; Department of Pharmacology, ISF College of Pharmacy, Moga (Punjab), India.
Singh G; Department of Pharmacology, ISF College of Pharmacy, Moga (Punjab), India.
Mohapatra L; Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Lucknow (UP), India.

Chin J Integr Med ; 28(2): 185-192, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34268649

Asunto(s)

Probióticos; Sepsis; Animales; Humanos; Inflamación; Ratones; Probióticos/uso terapéutico; Sepsis/terapia; Factor de Necrosis Tumoral alfa

Palabras clave

immune system; microbial flora; probiotics; sepsis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sepsis / Probióticos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Chin J Integr Med Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google